Long-Term Outcomes of Pegcetacoplan for GA Show Promise at AshTip Solution.

AshTip NewsLetter |SEATTLE, Washington — Treatment with pegcetacoplan (Syfovre, Apellis Pharmaceuticals) produced clinically meaningful reductions in the growth of geographic atrophy (GA) lesions through month 30, according to interim results presented at the annual meeting of the American Society

Medscape

Long-Term Outcomes of Pegcetacoplan for GA Show Promise

Long-Term Outcomes of Pegcetacoplan for GA Show Promise

SEATTLE, Washington — Treatment with pegcetacoplan (Syfovre, Apellis Pharmaceuticals) produced clinically meaningful reductions in the growth of geographic atrophy (GA) lesions through month 30, according to interim results presented at the annual meeting of the American Society of Retina Specialists.